US Food and drug Administration issues complete response letter regarding
Schering-Plough Corp. announced today the US Food and Drug Administration has issued a complete response letter to the company's supplemental Biologics License Application regarding PEGINTRON® for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy.
US officials say North Korea is rejecting American food aid, although no reason was offered.